The amyloid-beta peptide of Alzheimer's disease binds Cu(I) in a linear bis-his coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMC 2935688)

Published in J Am Chem Soc on December 31, 2008

Authors

Jason Shearer1, Veronika A Szalai

Author Affiliations

1: Department of Chemistry/216, University of NevadaReno, 1664 North Virginia Street, Reno, Nevada 89557, USA.

Articles citing this

Small molecule modulators of copper-induced Abeta aggregation. J Am Chem Soc (2009) 1.30

Model peptides provide new insights into the role of histidine residues as potential ligands in human cellular copper acquisition via Ctr1. J Am Chem Soc (2011) 1.01

Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease. Biochemistry (2009) 0.96

Local structure and global patterning of Cu2+ binding in fibrillar amyloid-β [Aβ(1-40)] protein. J Am Chem Soc (2012) 0.92

Identification of the minimal copper(II)-binding alpha-synuclein sequence. Inorg Chem (2009) 0.90

Importance of dynamical processes in the coordination chemistry and redox conversion of copper amyloid-beta complexes. J Biol Inorg Chem (2009) 0.86

Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates. J Phys Chem B (2010) 0.86

Electrochemical and homogeneous electron transfers to the Alzheimer amyloid-beta copper complex follow a preorganization mechanism. Proc Natl Acad Sci U S A (2010) 0.85

Lumenal loop M672-P707 of the Menkes protein (ATP7A) transfers copper to peptidylglycine monooxygenase. J Am Chem Soc (2012) 0.85

Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology. Front Aging Neurosci (2014) 0.85

Cu K-edge X-ray absorption spectroscopy reveals differential copper coordination within amyloid-β oligomers compared to amyloid-β monomers. Chem Commun (Camb) (2010) 0.85

Synthetic Flavonoids, Aminoisoflavones: Interaction and Reactivity with Metal-Free and Metal-Associated Amyloid-β Species. Chem Sci (2014) 0.83

Evidence for copper-dioxygen reactivity during alpha-synuclein fibril formation. J Am Chem Soc (2010) 0.81

Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle. J Biol Chem (2014) 0.80

On the involvement of copper binding to the N-terminus of the amyloid Beta Peptide of Alzheimer's disease: a computational study on model systems. Int J Alzheimers Dis (2011) 0.79

Combined EXAFS and DFT structure calculations provide structural insights into the 1:1 multi-histidine complexes of Cu(II) , Cu(I) , and Zn(II) with the tandem octarepeats of the mammalian prion protein. Chemistry (2014) 0.78

A Redox-Active, Compact Molecule for Cross-Linking Amyloidogenic Peptides into Nontoxic, Off-Pathway Aggregates: In Vitro and In Vivo Efficacy and Molecular Mechanisms. J Am Chem Soc (2015) 0.77

On the generation of OH(·) radical species from H2O2 by Cu(I) amyloid beta peptide model complexes: a DFT investigation. J Biol Inorg Chem (2015) 0.76

Identification of key structural features of the elusive Cu-Aβ complex that generates ROS in Alzheimer's disease. Chem Sci (2017) 0.76

Effect of C-terminal residues of Aβ on copper binding affinity, structural conversion and aggregation. PLoS One (2014) 0.76

Structure of the Reduced Copper Active Site in Preprocessed Galactose Oxidase: Ligand Tuning for One-Electron O2 Activation in Cofactor Biogenesis. J Am Chem Soc (2016) 0.75

Synthesis aided structural determination of amyloid-β(1-15) glycopeptides, new biomarkers for Alzheimer's disease. Chem Commun (Camb) (2014) 0.75

Copper ligation to soluble oligomers of the English mutant of the amyloid-β peptide yields a linear Cu(I) site that is resistant to O2 oxidation. Chem Commun (Camb) (2013) 0.75

Sequence proximity between Cu(II) and Cu(I) binding sites of human copper transporter 1 model peptides defines reactivity with ascorbate and O2. J Inorg Biochem (2015) 0.75

A Peroxynitrite Dicopper Complex: Formation via Cu-NO and Cu-O2 Intermediates and Reactivity via O-O Cleavage Chemistry. J Am Chem Soc (2016) 0.75

Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation. Biophys Rev (2017) 0.75

Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol (2017) 0.75

Glycation of Lys-16 and Arg-5 in amyloid-β and the presence of Cu(2+) play a major role in the oxidative stress mechanism of Alzheimer's disease. J Biol Inorg Chem (2017) 0.75

Vitamin C, Aging and Alzheimer's Disease. Nutrients (2017) 0.75

Articles cited by this

Global prevalence of dementia: a Delphi consensus study. Lancet (2005) 23.30

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res (2008) 5.29

Protein Radicals in Enzyme Catalysis. Chem Rev (1998) 5.03

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem (2002) 4.20

Reactivity of dioxygen-copper systems. Chem Rev (2004) 3.34

Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol (2006) 3.01

Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. J Am Chem Soc (2004) 2.79

Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci (2000) 2.36

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem (1999) 2.30

Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry (2002) 2.16

Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J Struct Biol (2005) 2.15

Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Mol Med (2008) 1.90

Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry (2003) 1.89

Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem (2001) 1.64

Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci (2007) 1.59

Vascular risk factors and Alzheimer's disease. Expert Rev Neurother (2008) 1.47

Alzheimer disease pathology as a host response. J Neuropathol Exp Neurol (2008) 1.45

Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry (2000) 1.42

Synthesis and X-ray absorption spectroscopy structural studies of Cu(I) complexes of histidylhistidine peptides: the predominance of linear 2-coordinate geometry. J Am Chem Soc (2007) 1.40

Metals and Alzheimer's disease. J Alzheimers Dis (2006) 1.39

Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques. J Biol Chem (2004) 1.38

A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J Neurosci (2002) 1.37

Protein misfolding and disease: from the test tube to the organism. Curr Opin Chem Biol (2008) 1.35

Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. Biochemistry (2004) 1.30

Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis Assoc Disord (2007) 1.29

Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid. FASEB J (2004) 1.29

High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide. FEBS J (2007) 1.22

Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev Proteomics (2008) 1.21

Amyloid-beta binds Cu2+ in a mononuclear metal ion binding site. J Am Chem Soc (2004) 1.19

N-Terminal deletions modify the Cu2+ binding site in amyloid-beta. Biochemistry (2005) 1.19

Metal ion and metal chelate catalyzed oxidation of ascorbic acid by molecular oxygen. I. Cupric and ferric ion catalyzed oxidation. J Am Chem Soc (1967) 1.14

Methylation of the imidazole side chains of the Alzheimer disease amyloid-beta peptide results in abolition of superoxide dismutase-like structures and inhibition of neurotoxicity. J Biol Chem (2005) 1.14

Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance. Biochemistry (2007) 1.12

Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state. Chembiochem (2007) 1.10

X-ray spectroscopy of nitrile hydratase at pH 7 and 9. Biochemistry (1996) 1.09

Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide. Biochemistry (2008) 1.08

Copper-catalyzed protein oxidation and its modulation by carbon dioxide: enhancement of protein radicals in cells. J Biol Chem (2005) 1.06

Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptide. Biochemistry (2007) 1.06

Measurement of cerebrospinal fluid oxygen partial pressure in humans using MRI. Magn Reson Med (2005) 1.05

Coordination abilities of the 1-16 and 1-28 fragments of beta-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study. J Inorg Biochem (2003) 1.05

NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease. J Am Chem Soc (2006) 1.02

Metal binding in amyloid beta-peptides shows intra- and inter-peptide coordination modes. Eur Biophys J (2006) 1.01

Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. Biochemistry (2007) 1.01

Development of a methodology based on metal-catalyzed oxidation reactions and mass spectrometry to determine the metal binding sites in copper metalloproteins. Anal Chem (2003) 0.96

Metal ion and metal chelate catalyzed oxidation of ascorbic acid by molecular oxygen. II. Cupric and ferric chelate catalyzed oxidation. J Am Chem Soc (1967) 0.95

Role of calcium in the pathogenesis of Alzheimer's disease and transgenic models. Subcell Biochem (2007) 0.92

The copper(II) adduct of the unstructured region of the amyloidogenic fragment derived from the human prion protein is redox-active at physiological pH. Inorg Chem (2007) 0.92

Products of Cu(II)-catalyzed oxidation in the presence of hydrogen peroxide of the 1-10, 1-16 fragments of human and mouse beta-amyloid peptide. J Inorg Biochem (2004) 0.91

The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease. Biophys J (2008) 0.90

Structural and thermodynamical properties of CuII amyloid-beta16/28 complexes associated with Alzheimer's disease. J Biol Inorg Chem (2006) 0.90

Ab initio modelling of the structure and redox behaviour of copper(I) bound to a His-His model peptide: relevance to the beta-amyloid peptide of Alzheimer's disease. J Biol Inorg Chem (2006) 0.89

Investigations of the molecular mechanism of metal-induced Abeta (1-40) amyloidogenesis. Biochemistry (2007) 0.89

Cu(II)-catalyzed oxidation of beta-amyloid peptide targets His13 and His14 over His6: Detection of 2-Oxo-histidine by HPLC-MS/MS. Chem Res Toxicol (2002) 0.88

Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease. Biopolymers (2006) 0.87

Mechanistic studies of Cu(II) binding to amyloid-beta peptides and the fluorescence and redox behaviors of the resulting complexes. J Phys Chem B (2008) 0.86

Reversible binding of nitric oxide to tyrosyl radicals in photosystem II. Nitric oxide quenches formation of the S3 EPR signal species in acetate-inhibited photosystem II. Biochemistry (1996) 0.86

Substrate mediated reduction of copper-amyloid-beta complex in Alzheimer's disease. Chem Commun (Camb) (2008) 0.86

Computational study of the binding of CuII to Alzheimer's amyloid-beta peptide: do Abeta42 and Abeta40 bind copper in identical fashion? J Biol Inorg Chem (2008) 0.85

Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry. J Inorg Biochem (2005) 0.84

A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques. Anal Chem (1998) 0.84

Redox properties of Met(35) in neurotoxic beta-amyloid peptide. A molecular modeling study. Chem Res Toxicol (2002) 0.84

Cu(II) interaction with N-terminal fragments of human and mouse beta-amyloid peptide. J Inorg Biochem (2001) 0.83

Dityrosine cross-linked Abeta peptides: fibrillar beta-structure in Abeta(1-40) is conducive to formation of dityrosine cross-links but a dityrosine cross-link in Abeta(8-14) does not induce beta-structure. Chem Res Toxicol (2003) 0.83

Influence of chelators and iron ions on the production and degradation of H2O2 by beta-amyloid-copper complexes. J Inorg Biochem (2006) 0.81

Formation and decay of the S3 EPR signal species in acetate-inhibited photosystem II. Biochemistry (1996) 0.80

The role of alpha-synuclein in neurodegenerative diseases: a potential target for new treatment strategies? Neurodegener Dis (2008) 0.80

Characterization of the interaction between manganese and tyrosine Z in acetate-inhibited photosystem II. Biochemistry (1998) 0.78

From presenilinase to gamma-secretase, cleave to capacitate. Curr Alzheimer Res (2008) 0.78

Selective Cu2+/ascorbate-dependent oxidation of alzheimer's disease beta-amyloid peptides. Ann N Y Acad Sci (2004) 0.78

[Oxygen pressure in the cerebrospinal fluid]. Wien Med Wochenschr (1966) 0.77

CISTERNAL FLUID OXYGEN TENSION IN MAN. Neurology (1964) 0.76

Articles by these authors

Amyloid-beta binds Cu2+ in a mononuclear metal ion binding site. J Am Chem Soc (2004) 1.19

N-Terminal deletions modify the Cu2+ binding site in amyloid-beta. Biochemistry (2005) 1.19

Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-beta peptide. Biochemistry (2008) 1.08

Detection of attomole quantities [correction of quantitites] of DNA targets on gold microelectrodes by electrocatalytic nucleobase oxidation. Anal Chem (2003) 1.06

Parallel-stranded guanine quadruplex interactions with a copper cationic porphyrin. Biochemistry (2004) 0.99

Affinity of Cu+ for the copper-binding domain of the amyloid-β peptide of Alzheimer's disease. Inorg Chem (2011) 0.99

Local structure and global patterning of Cu2+ binding in fibrillar amyloid-β [Aβ(1-40)] protein. J Am Chem Soc (2012) 0.92

Role of aspartate-1 in Cu(II) binding to the amyloid-beta peptide of Alzheimer's disease. J Am Chem Soc (2007) 0.89

Cu K-edge X-ray absorption spectroscopy reveals differential copper coordination within amyloid-β oligomers compared to amyloid-β monomers. Chem Commun (Camb) (2010) 0.85

N-methylmesoporphyrin IX fluorescence as a reporter of strand orientation in guanine quadruplexes. FEBS J (2014) 0.84

End-stacking of copper cationic porphyrins on parallel-stranded guanine quadruplexes. J Biol Inorg Chem (2007) 0.84

Fluorescence of unmodified oligonucleotides: A tool to probe G-quadruplex DNA structure. Biopolymers (2009) 0.83

Synapsable quadruplex-mediated fibers. Nanoscale Res Lett (2013) 0.75

Design considerations for enhancing absorption in semiconductors on metals through surface plasmon polaritons. Phys Chem Chem Phys (2014) 0.75

Molecular Precision at Micrometer Length Scales: Hierarchical Assembly of DNA-Protein Nanostructures. ACS Nano (2017) 0.75

DNA oxidation in anionic reverse micelles: ruthenium-mediated damage at Guanine in single- and double-stranded DNA. Inorg Chem (2006) 0.75

Oxidation of guanine in double-stranded DNA by [Ru(bpy)2dppz]Cl2 in cationic reverse micelles. Inorg Chem (2007) 0.75